Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIAN HEALTHCARE vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIAN HEALTHCARE GLENMARK PHARMA CIAN HEALTHCARE/
GLENMARK PHARMA
 
P/E (TTM) x - -31.4 - View Chart
P/BV x 0.9 2.9 31.5% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 CIAN HEALTHCARE   GLENMARK PHARMA
EQUITY SHARE DATA
    CIAN HEALTHCARE
Mar-23
GLENMARK PHARMA
Mar-23
CIAN HEALTHCARE/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs32487 6.5%   
Low Rs12349 3.4%   
Sales per share (Unadj.) Rs27.4460.4 6.0%  
Earnings per share (Unadj.) Rs0.813.4 6.1%  
Cash flow per share (Unadj.) Rs3.035.0 8.5%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs23.0335.1 6.9%  
Shares outstanding (eoy) m25.00282.17 8.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.80.9 88.1%   
Avg P/E ratio x27.031.3 86.5%  
P/CF ratio (eoy) x7.411.9 61.6%  
Price / Book Value ratio x1.01.2 76.5%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m549117,953 0.5%   
No. of employees `000NANA-   
Total wages/salary Rs m8927,810 0.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m686129,901 0.5%  
Other income Rs m63,168 0.2%   
Total revenues Rs m692133,069 0.5%   
Gross profit Rs m13115,125 0.9%  
Depreciation Rs m546,113 0.9%   
Interest Rs m633,496 1.8%   
Profit before tax Rs m208,685 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m04,911 -0.0%   
Profit after tax Rs m203,774 0.5%  
Gross profit margin %19.111.6 164.1%  
Effective tax rate %-1.956.5 -3.4%   
Net profit margin %3.02.9 101.8%  
BALANCE SHEET DATA
Current assets Rs m74298,737 0.8%   
Current liabilities Rs m65350,455 1.3%   
Net working cap to sales %13.137.2 35.2%  
Current ratio x1.12.0 58.1%  
Inventory Days Days947 1,407.0%  
Debtors Days Days1,396115 1,212.1%  
Net fixed assets Rs m76276,920 1.0%   
Share capital Rs m250282 88.6%   
"Free" reserves Rs m32594,281 0.3%   
Net worth Rs m57594,563 0.6%   
Long term debt Rs m29438,521 0.8%   
Total assets Rs m1,605175,658 0.9%  
Interest coverage x1.33.5 37.8%   
Debt to equity ratio x0.50.4 125.5%  
Sales to assets ratio x0.40.7 57.8%   
Return on assets %5.24.1 125.4%  
Return on equity %3.54.0 88.5%  
Return on capital %9.59.2 104.3%  
Exports to sales %13.70-   
Imports to sales %00-   
Exports (fob) Rs m94NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9446,464 0.2%   
Fx outflow Rs m012,712 0.0%   
Net fx Rs m9433,751 0.3%   
CASH FLOW
From Operations Rs m486,254 0.8%  
From Investments Rs m26-5,285 -0.5%  
From Financial Activity Rs m-74-775 9.6%  
Net Cashflow Rs m0325 -0.0%  

Share Holding

Indian Promoters % 49.6 46.7 106.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 34.7 -  
FIIs % 0.0 23.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.4 53.4 94.4%  
Shareholders   672 209,931 0.3%  
Pledged promoter(s) holding % 18.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIAN HEALTHCARE With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on CIAN HEALTHCARE vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

CIAN HEALTHCARE vs Glenmark Pharma Share Price Performance

Period CIAN HEALTHCARE Glenmark Pharma S&P BSE HEALTHCARE
1-Day 0.19% -0.57% 1.18%
1-Month -8.78% 5.16% -0.75%
1-Year -26.18% 112.94% 61.82%
3-Year CAGR 22.48% 27.51% 18.16%
5-Year CAGR -19.59% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the CIAN HEALTHCARE share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of CIAN HEALTHCARE hold a 49.6% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of CIAN HEALTHCARE and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, CIAN HEALTHCARE paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of CIAN HEALTHCARE, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.